179 related articles for article (PubMed ID: 22363757)
1. The potential role of ORM2 in the development of colorectal cancer.
Zhang X; Xiao Z; Liu X; Du L; Wang L; Wang S; Zheng N; Zheng G; Li W; Zhang X; Dong Z; Zhuang X; Wang C
PLoS One; 2012; 7(2):e31868. PubMed ID: 22363757
[TBL] [Abstract][Full Text] [Related]
2. High-throughput proteomics integrated with gene microarray for discovery of colorectal cancer potential biomarkers.
Yu J; Li X; Zhong C; Li D; Zhai X; Hu W; Guo C; Yuan Y; Zheng S
Oncotarget; 2016 Nov; 7(46):75279-75292. PubMed ID: 27661117
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of plasma ORM2 levels in patients with stage II colorectal cancer.
Gao F; Zhang X; Whang S; Zheng C
Ann Clin Lab Sci; 2014; 44(4):388-93. PubMed ID: 25361921
[TBL] [Abstract][Full Text] [Related]
4. Identification and Verification of Two Novel Differentially Expressed Proteins from Non-neoplastic Mucosa and Colorectal Carcinoma Via iTRAQ Combined with Liquid Chromatography-Mass Spectrometry.
Bai Y; Wang J; Gao Z; Dai E
Pathol Oncol Res; 2020 Apr; 26(2):967-976. PubMed ID: 30927204
[TBL] [Abstract][Full Text] [Related]
5. Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry.
Zhang J; Song MQ; Zhu JS; Zhou Z; Xu ZP; Chen WX; Chen NW
Int J Immunopathol Pharmacol; 2011; 24(4):849-59. PubMed ID: 22230392
[TBL] [Abstract][Full Text] [Related]
6. Proteomic profiling of a mouse model of acute intestinal Apc deletion leads to identification of potential novel biomarkers of human colorectal cancer (CRC).
Hammoudi A; Song F; Reed KR; Jenkins RE; Meniel VS; Watson AJ; Pritchard DM; Clarke AR; Jenkins JR
Biochem Biophys Res Commun; 2013 Oct; 440(3):364-70. PubMed ID: 23998936
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis of minute amount of colonic biopsies by enteroscopy sampling.
Liu X; Xu Y; Meng Q; Zheng Q; Wu J; Wang C; Jia W; Figeys D; Chang Y; Zhou H
Biochem Biophys Res Commun; 2016 Aug; 476(4):286-292. PubMed ID: 27230957
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of type I collagen during tumorigenesis of colorectal cancer revealed by quantitative proteomic analysis.
Zou X; Feng B; Dong T; Yan G; Tan B; Shen H; Huang A; Zhang X; Zhang M; Yang P; Zheng M; Zhang Y
J Proteomics; 2013 Dec; 94():473-85. PubMed ID: 24332065
[TBL] [Abstract][Full Text] [Related]
9. Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer.
Ma Y; Peng J; Liu W; Zhang P; Huang L; Gao B; Shen T; Zhou Y; Chen H; Chu Z; Zhang M; Qin H
Mol Cell Proteomics; 2009 Aug; 8(8):1878-90. PubMed ID: 19460759
[TBL] [Abstract][Full Text] [Related]
10. Proteomic Characterization of Colorectal Cancer Cells versus Normal-Derived Colon Mucosa Cells: Approaching Identification of Novel Diagnostic Protein Biomarkers in Colorectal Cancer.
Ludvigsen M; Thorlacius-Ussing L; Vorum H; Moyer MP; Stender MT; Thorlacius-Ussing O; Honoré B
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32422974
[TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling.
de Wit M; Kant H; Piersma SR; Pham TV; Mongera S; van Berkel MP; Boven E; Pontén F; Meijer GA; Jimenez CR; Fijneman RJ
J Proteomics; 2014 Mar; 99():26-39. PubMed ID: 24418523
[TBL] [Abstract][Full Text] [Related]
12. Proteomic profiling of proteins associated with lymph node metastasis in colorectal cancer.
Ma Y; Zhao M; Zhong J; Shi L; Luo Q; Liu J; Wang J; Yuan X; Huang C
J Cell Biochem; 2010 Aug; 110(6):1512-9. PubMed ID: 20524204
[TBL] [Abstract][Full Text] [Related]
13. iTRAQ-based quantitative analysis of cancer-derived secretory proteome reveals TPM2 as a potential diagnostic biomarker of colorectal cancer.
Ma Y; Xiao T; Xu Q; Shao X; Wang H
Front Med; 2016 Sep; 10(3):278-85. PubMed ID: 27283175
[TBL] [Abstract][Full Text] [Related]
14. Identification of Differentially Expressed Proteins in the Serum of Colorectal Cancer Patients Using 2D-DIGE Proteomics Analysis.
Lim LC; Looi ML; Zakaria SZ; Sagap I; Rose IM; Chin SF; Jamal R
Pathol Oncol Res; 2016 Jan; 22(1):169-77. PubMed ID: 26463353
[TBL] [Abstract][Full Text] [Related]
15. Revelation of Proteomic Indicators for Colorectal Cancer in Initial Stages of Development.
Kopylov AT; Stepanov AA; Malsagova KA; Soni D; Kushlinsky NE; Enikeev DV; Potoldykova NV; Lisitsa AV; Kaysheva AL
Molecules; 2020 Jan; 25(3):. PubMed ID: 32023884
[No Abstract] [Full Text] [Related]
16. Plasma orosomucoid 2 as a potential risk marker of cholangiocarcinoma.
Rucksaken R; Charoensuk L; Pinlaor P; Pairojkul C; Khuntikeo N; Pinlaor S
Cancer Biomark; 2017; 18(1):27-34. PubMed ID: 27814272
[TBL] [Abstract][Full Text] [Related]
17. Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family.
Peltier J; Roperch JP; Audebert S; Borg JP; Camoin L
J Proteomics; 2016 Oct; 148():139-48. PubMed ID: 27492143
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of orosomucoid 2 acts as a prognostic factor associated with cancer-promoting pathways in liver cancer.
Zhu HZ; Zhou WJ; Wan YF; Ge K; Lu J; Jia CK
World J Gastroenterol; 2020 Feb; 26(8):804-817. PubMed ID: 32148378
[TBL] [Abstract][Full Text] [Related]
19. Identification of MST1 as a potential early detection biomarker for colorectal cancer through a proteomic approach.
Yu J; Zhai X; Li X; Zhong C; Guo C; Yang F; Yuan Y; Zheng S
Sci Rep; 2017 Oct; 7(1):14265. PubMed ID: 29079854
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patients.
Zhang Q; Wang XQ; Wang J; Cui SJ; Lou XM; Yan B; Qiao J; Jiang YH; Zhang LJ; Yang PY; Liu F
Oncotarget; 2015 Jun; 6(17):15095-110. PubMed ID: 25945835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
